184 related articles for article (PubMed ID: 32649824)
1. Identification of a New Allosteric Binding Site for Cocaine in Dopamine Transporter.
Xu L; Chen LY
J Chem Inf Model; 2020 Aug; 60(8):3958-3968. PubMed ID: 32649824
[TBL] [Abstract][Full Text] [Related]
2. Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in
Refai O; Aggarwal S; Cheng MH; Gichi Z; Salvino JM; Bahar I; Blakely RD; Mortensen OV
Mol Pharmacol; 2022 Mar; 101(3):123-131. PubMed ID: 34906999
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
Jean B; Surratt CK; Madura JD
J Mol Graph Model; 2017 Sep; 76():143-151. PubMed ID: 28734204
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter.
Aggarwal S; Liu X; Rice C; Menell P; Clark PJ; Paparoidamis N; Xiao YC; Salvino JM; Fontana ACK; España RA; Kortagere S; Mortensen OV
ACS Chem Neurosci; 2019 Aug; 10(8):3718-3730. PubMed ID: 31184115
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs.
Krout D; Pramod AB; Dahal RA; Tomlinson MJ; Sharma B; Foster JD; Zou MF; Boatang C; Newman AH; Lever JR; Vaughan RA; Henry LK
Biochem Pharmacol; 2017 Oct; 142():204-215. PubMed ID: 28734777
[TBL] [Abstract][Full Text] [Related]
6. Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter.
Aggarwal S; Cheng MH; Salvino JM; Bahar I; Mortensen OV
Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34199621
[TBL] [Abstract][Full Text] [Related]
7. Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters.
Merchant BA; Madura JD
J Mol Graph Model; 2012 Sep; 38():1-12. PubMed ID: 23079638
[TBL] [Abstract][Full Text] [Related]
8. Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.
Dehnes Y; Shan J; Beuming T; Shi L; Weinstein H; Javitch JA
Neurochem Int; 2014 Jul; 73():4-15. PubMed ID: 24576496
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.
Fagan RR; Kearney PJ; Luethi D; Bolden NC; Sitte HH; Emery P; Melikian HE
Mol Psychiatry; 2021 Dec; 26(12):7793-7802. PubMed ID: 34471250
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.
Sun WL; Quizon PM; Yuan Y; Zhang W; Ananthan S; Zhan CG; Zhu J
Sci Rep; 2017 Jun; 7(1):3694. PubMed ID: 28623359
[TBL] [Abstract][Full Text] [Related]
11. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine.
Kohut SJ; Hiranita T; Hong SK; Ebbs AL; Tronci V; Green J; Garcés-Ramírez L; Chun LE; Mereu M; Newman AH; Katz JL; Tanda G
Biol Psychiatry; 2014 Nov; 76(10):802-9. PubMed ID: 24853388
[TBL] [Abstract][Full Text] [Related]
12. Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding.
Cheng MH; Block E; Hu F; Cobanoglu MC; Sorkin A; Bahar I
Front Neurol; 2015; 6():134. PubMed ID: 26106364
[TBL] [Abstract][Full Text] [Related]
13. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
14. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
[TBL] [Abstract][Full Text] [Related]
15. Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release.
Keighron JD; Bonaventura J; Li Y; Yang JW; DeMarco EM; Hersey M; Cao J; Sandtner W; Michaelides M; Sitte HH; Newman AH; Tanda G
Transl Psychiatry; 2023 Jun; 13(1):202. PubMed ID: 37311803
[TBL] [Abstract][Full Text] [Related]
16. Identification of the benztropine analog [
Tomlinson MJ; Krout D; Pramod AB; Lever JR; Newman AH; Henry LK; Vaughan RA
Neurochem Int; 2019 Feb; 123():34-45. PubMed ID: 30125594
[TBL] [Abstract][Full Text] [Related]
17. The Dopamine Transporter Recycles via a Retromer-Dependent Postendocytic Mechanism: Tracking Studies Using a Novel Fluorophore-Coupling Approach.
Wu S; Fagan RR; Uttamapinant C; Lifshitz LM; Fogarty KE; Ting AY; Melikian HE
J Neurosci; 2017 Sep; 37(39):9438-9452. PubMed ID: 28847807
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.
Moritz AE; Foster JD; Gorentla BK; Mazei-Robison MS; Yang JW; Sitte HH; Blakely RD; Vaughan RA
J Biol Chem; 2013 Jan; 288(1):20-32. PubMed ID: 23161550
[TBL] [Abstract][Full Text] [Related]
19. Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.
Hong WC; Amara SG
J Biol Chem; 2010 Oct; 285(42):32616-26. PubMed ID: 20688912
[TBL] [Abstract][Full Text] [Related]
20. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.
Hong WC; Yano H; Hiranita T; Chin FT; McCurdy CR; Su TP; Amara SG; Katz JL
J Biol Chem; 2017 Jul; 292(27):11250-11261. PubMed ID: 28495886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
